Position in QGEN
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$13,272,925
+$6,040,500 QoQ
Shares Held
339,461
+87.9% QoQ
Ownership
0.164%
of shares outstanding
% of Portfolio
0.59%
of 13F equity value
Holder Rank
#64
of 332 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in QGEN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Moors & Cabot, Inc. holds $18,215,220 across 9 Diagnostics & Research names. QGEN ranks #1 (72.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | QGEN |
Qiagen N.V.
This page
|
339,461 | $13,272,925 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
2,681 | $1,344,146 | |
| 3 | ILMN |
Illumina, Inc.
|
5,000 | $879,150 | |
| 4 | WAT |
Waters Corp /De/
|
2,019 | $757,205 | |
| 5 | DHR |
Danaher Corp /De/
|
3,437 | $654,679 | |
| 6 | DGX |
Quest Diagnostics Inc
|
1,984 | $420,508 | |
| 7 | CRL |
Charles River Laboratories International, Inc.
|
1,731 | $392,573 | |
| 8 | RVTY |
Revvity, Inc.
|
2,375 | $264,242 |
All Filings in QGEN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,272,925 | 339,461 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $7,232,425 | 180,630 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $14,873,737 | 330,748 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $15,763,506 | 352,809 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $9,513,861 | 197,958 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $3,359,310 | 83,669 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $3,850,687 | 86,474 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $3,921,207 | 86,048 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $3,535,712 | 86,048 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $3,699,203 | 86,048 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $3,973,553 | 88,657 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $3,704,352 | 88,630 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $4,118,689 | 88,630 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $4,199,634 | 88,601 | Shares | Sole | 2023-05-05 | |
| 2022-12-31 | $4,559,885 | 88,601 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $3,774,455 | 88,601 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $4,315,754 | 88,601 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $4,480,339 | 88,601 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $5,081,985 | 88,601 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $4,725,383 | 88,601 | Shares | Sole | 2021-12-08 | |
| 2021-06-30 | $1,898,554 | 38,026 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $1,910,719 | 38,026 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $2,073,968 | 38,026 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $2,050,814 | 38,026 | Shares | Sole | 2020-11-09 | |
| 2020-03-31 | $2,040,333 | 47,526 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||